Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SPARTEINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 458 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Deiters, A; Wibbeling, B; Hoppe, D
      Enantio- and diastereoselective synthesis of a 3,4-divinylpyrrolidine via asymmetric deprotonation and cyclization of a 9-chloro-5-aza-2,7-nonadiene

      ADVANCED SYNTHESIS & CATALYSIS
    2. Castelot-Deliencourt, G; Roger, E; Pannecoucke, X; Quirion, JC
      Diastereoselective synthesis of chiral amidophosphonates by 1,5-asymmetricinduction

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    3. Belgsir, EM; Schafer, HJ
      Selective oxidation of carbohydrates on Nafion (R)-TEMPO-modified graphitefelt electrodes

      ELECTROCHEMISTRY COMMUNICATIONS
    4. Leis, HJ; Windischhofer, W; Raspotnig, G; Fauler, G
      Stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry for the quantitative analysis of paroxetine in human plasma

      JOURNAL OF MASS SPECTROMETRY
    5. Tsuzuki, D; Takemi, C; Yamamoto, S; Tamagake, K; Imaoka, S; Funae, Y; Kataoka, H; Shinoda, S; Narimatsu, S
      Functional evaluation of cytochrome P450 2D6 with Gly(42)Arg substitution expressed in Saccharomyces cerevisiae

      PHARMACOGENETICS
    6. Zanger, UM; Fischer, J; Raimundo, S; Stuven, T; Evert, BO; Schwab, M; Eichelbaum, M
      Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6

      PHARMACOGENETICS
    7. Wan, YJY; Poland, RE; Han, G; Konishi, T; Zheng, YP; Berman, N; Lin, KM
      Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in Southern California

      PHARMACOGENETICS
    8. Jazwinska-Tarnawska, E; Orzechowska-Juzwenko, K; Niewinski, P; Rzemislawska, Z; Loboz-Grudzien, K; Dmochowska-Perz, M; Slawin, J
      The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    9. Tan, YL; Widdowson, DA; Wilhelm, R
      Reversal of asymmetric induction in arenetricarbonyl-chromium(0) complexesvia dilithiation with the (-)-sparteine/BuLi system and enantioselective quench

      SYNLETT
    10. Baltes, E; Coupez, R; Giezek, H; Voss, G; Meyerhoff, C; Benedetti, MS
      Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    11. Slanar, O; Perlik, F; Jirasek, V
      Phenotype of cytochrome P450CYP2D6 in patients with familial adenomatous polyposis

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    12. Roh, HK; Chung, JY; Oh, DY; Park, CS; Svensson, JO; Dahl, ML; Bertilsson, L
      Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    13. Enggaard, TP; Poulsen, L; Arendt-Nielsen, L; Hansen, SH; Bjornsdottir, I; Gram, LF; Sindrup, SH
      The analgesic effect of codeine as compared to imipramine in different human experimental pain models

      PAIN
    14. Lessard, E; Yessine, MA; Hamelin, BA; Gauvin, C; Labbe, L; O'Hara, G; LeBlanc, J; Turgeon, J
      Diphenhydramine alters the disposition of venlafaxine through inhibition of CYP2D6 activity in humans

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    15. Gutierrez, R; Vazquez, J; Vazquez, RA; Reyes, Y; Toscano, RA; Martinez, M; Alvarez, C
      Chiral complexes by direct synthesis of a biomolecule and metal powders. Crystal structures of the dichloro[(-)-sparteine-N,N ']M(II) complexes (M = Cu, Zn)

      JOURNAL OF COORDINATION CHEMISTRY
    16. Alvan, G; Bertilsson, L; Dahl, ML; Ingelman-Sundberg, M; Sjoqvist, F
      Moving toward genetic profiling in patient care: The scope and rationale of pharmacogenetic/ecogenetic investigation

      DRUG METABOLISM AND DISPOSITION
    17. Prat, L; Dupas, G; Duflos, J; Queguiner, G; Bourguignon, J; Levacher, V
      Deracemization of alkyl diarylmethanes using (-)-sparteine or a chiral proton source

      TETRAHEDRON LETTERS
    18. Rajca, A; Wang, H; Bolshov, P; Rajca, S
      A Greek cross dodecaphenylene: sparteine-mediated asymmetric synthesis of chiral D-2-symmetric pi-conjugated tetra-o-phenylenes

      TETRAHEDRON
    19. Barberis, C; Voyer, N; Roby, J; Chenard, S; Tremblay, M; Labrie, P
      Rapid access to N-Boc phenylglycine derivatives via benzylic lithiation reactions

      TETRAHEDRON
    20. Tomooka, K
      Chiral coordinating agent-based enantiocontrol in carbanion reactions

      JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN
    21. Bergmann, TK; Bathum, L; Brosen, K
      Duplication of CYP2D6 predicts high clearance of desipramine but high clearance does not predict duplication of CYP2D6

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    22. Laqua, H; Frohlich, R; Wibbeling, B; Hoppe, D
      Synthesis of enantioenriched indene-derived bicyclic alcohols and tricyclic cyclopropanes via (-)-sparteine-mediated lithiation of a racemic precursor and kinetic resolution during the cyclocarbolithiation

      JOURNAL OF ORGANOMETALLIC CHEMISTRY
    23. Schroeder, G; Boczon, W; Leska, B; Eitner, K; Koziol, B; Brzezinski, B
      Studies of the complex formation between some proton sponges and Cu(II) cations

      JOURNAL OF MOLECULAR STRUCTURE
    24. Sato, T; Shibata, H; Seno, M
      Effect of sparteine on the photopolymerization of methyl and ethyl methacrylates with bis(cyclopentadienyl)titanium dichloride in a water-methanol mixture

      JOURNAL OF APPLIED POLYMER SCIENCE
    25. Laine, K; Tybring, G; Hartter, S; Andersson, K; Svensson, JO; Widen, J; Bertilsson, L
      Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    26. Kalow, W
      Perspectives in pharmacogenetics

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    27. Wiberg, KB; Bailey, WF
      Chiral diamines 4: A computational study of the enantioselective deprotonation of Boc-pyrrolidine with an alkyllithium in the presence of a chiral diamine

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    28. Williard, PG; Jacobson, MA
      Dianion aggregates derived from lithiation of N-silyl allylamine

      ORGANIC LETTERS
    29. Spieler, J; Huttenloch, O; Waldmann, H
      Synthesis of chiral amino alcohols embodying the bispidine framework and their application as ligands in enantioselectively catalyzed additions to C=O and C=C groups

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    30. Goldfuss, B; Steigelmann, M; Rominger, F
      Chirally modified n-butyllithium: Tuning the composition, structure, and enantioselectivity with modular fencholates

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    31. Deiters, A; Frohlich, R; Hoppe, D
      Enantioselective synthesis of functionalized 1,5-cyclononadienes by intramolecular cycloalkylation under alpha,alpha '-diallyl coupling

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    32. Vree, TB; Van Dongen, RTM; Koopman-Kimenai, PM
      Codeine analgesia is due to codeine-6-glucuronide, not morphine

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    33. Roberts, R; Sullivan, P; Joyce, P; Kennedy, MA
      Rapid and comprehensive determination of cytochrome P450CYP2D6 poor metabolizer genotypes by multiplex polymerase chain reaction

      HUMAN MUTATION
    34. Raimundo, S; Fischer, R; Eichelbaum, M; Griese, EU; Schwab, M; Zanger, UM
      Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6

      PHARMACOGENETICS
    35. Laforest, L; Wikman, H; Benhamou, S; Saarikoski, ST; Bouchardy, C; Hirvonen, A; Dayer, P; Husgafvel-Pursiainen, K
      CYP2D6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships

      EUROPEAN JOURNAL OF CANCER
    36. Gawley, RE; Zhang, QH; McPhail, AT
      2-lithio-N-BOC-thiazolidines as chiral acyl anion synthons: evaluation of facial stereoselectivity in the addition of chiral organolithiums to aldehydes

      TETRAHEDRON-ASYMMETRY
    37. Anzenbacherova, E; Anzenbacher, P; Perlik, F; Kvetina, J
      Use of a propafenone metabolic ratio as a measure of CYP2D6 activity

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    38. Prasad, KRK; Hoppe, D
      Applications of homoallylic alcohols derived from (-)-sparteine-mediated asymmetric homoaldolization: Entry to 5-to 8-membered unsaturated oxacycles through metathesis reaction

      SYNLETT
    39. Tomooka, K; Komine, N; Nakai, T
      External chiral ligand-induced enantioselective versions of the [2,3]-Wittig sigmatropic rearrangement

      CHIRALITY
    40. Bernard, SA; Bruera, E
      Drug interactions in palliative care

      JOURNAL OF CLINICAL ONCOLOGY
    41. Dalen, P; Dahl, ML; Andersson, K; Bertilsson, L
      Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    42. Kathiramalainathan, K; Kaplan, HL; Romach, MK; Busto, UE; Li, NY; Sawe, J; Tyndale, RF; Sellers, EM
      Inhibition of cytochrome P450 2D6 modifies codeine abuse liability

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    43. Poolsup, N; Po, ALW; Knight, TL
      Pharmacogenetics and psychopharmacotherapy

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    44. Albers, LJ; Reist, C; Vu, RL; Fujimoto, K; Ozdemir, V; Helmeste, D; Poland, R; Tang, SW
      Effect of venlafaxine on imipramine metabolism

      PSYCHIATRY RESEARCH
    45. Hiemke, C; Hartter, S
      Pharmacokinetics of selective serotonin reuptake inhibitors

      PHARMACOLOGY & THERAPEUTICS
    46. Gex-Fabry, M; Haffen, E; Paintaud, G; Bizouard, P; Sechter, D; Bechtel, PR; Balant, LP
      Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: Model evaluation

      THERAPEUTIC DRUG MONITORING
    47. Boczon, W; Koziol, B
      Synthesis and structure of 17 beta-isopropyllupanine N-oxide and its perchlorate salt

      POLISH JOURNAL OF CHEMISTRY
    48. Lee, YM; Chung, GW; Kwon, MA; Choi, SN
      (-)-Sparteine copper(II) diacetate

      ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS
    49. Burritt, EA; Provenza, FD
      Role of toxins in intake of varied diets by sheep

      JOURNAL OF CHEMICAL ECOLOGY
    50. Attitallah, S; Berard, M; Belkahia, C; Bechtel, YC; Bechtel, PR
      Similarities and/or dissimilarities of CYP2D6 polymorphism in three Tunisian ethnic groups: Arabs, Berbers, Numides

      THERAPIE
    51. Norsikian, S; Baudry, M; Normant, JF
      Regio- and enantioselective carbolithiation of non-activated C=C bonds

      TETRAHEDRON LETTERS
    52. Kowalczyk, BA
      Total synthesis of RS-42358 and analogs using lateral lithiation

      SYNTHESIS-STUTTGART
    53. Sano, S; Nagao, Y
      Asymmetric synthesis of alpha-substituted serines

      JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN
    54. O'Neil, WM; Gilfix, BM; Markoglou, N; Di Girolamo, A; Tsoukas, CM; Wainer, IW
      Genotype and phenotype of cytochrome P-450 2D6 in human immunodeficiency virus-positive patients and patients with acquired immunodeficiency syndrome

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    55. Yoon, YR; Cha, IJ; Shon, JH; Lim, KA; Cha, YN; Jang, IJ; Park, CW; Shin, SG; Flockhart, DA; Shin, JG
      Relationship of paroxetine disposition to metoprolol metabolic ratio and CPsi P2D6*10 genotype of Korean subjects

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    56. Nakamura, S; Nakagawa, R; Watanabe, Y; Toru, T
      Highly enantioselective reactions of configurationally labile alpha-thioorganolithiums using chiral bis(oxazoline)s via two different enantiodetermining steps

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    57. Tsuji, K; Wagner, P; Davis, ME
      High-silica molecular sieve syntheses using the sparteine related compounds as structure-directing agents

      MICROPOROUS AND MESOPOROUS MATERIALS
    58. Weber, WW
      Populations and genetic polymorphisms

      MOLECULAR DIAGNOSIS
    59. Bachus, R; Bickel, U; Thomsen, T; Roots, I; Kewitz, H
      The O-demethylation of the antidementia drug galanthamine is catalysed by cytochrome P450 2D6

      PHARMACOGENETICS
    60. Lessard, E; Hamelin, BA; Labbe, L; O'Hara, G; Belanger, PM; Turgeon, J
      Involvement of CYP2D6 activity in the N-oxidation of procainamide in man

      PHARMACOGENETICS
    61. Dalen, P; Dahl, ML; Eichelbaum, M; Bertilsson, L; Wilkinson, GR
      Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes

      PHARMACOGENETICS
    62. Wennerholm, A; Johansson, I; Massele, AY; Jande, M; Alm, C; Aden-Abdi, Y; Dahl, ML; Ingelman-Sundberg, M; Bertilsson, L; Gustafsson, LL
      Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotype

      PHARMACOGENETICS
    63. Griese, EU; Asante-Poku, S; Ofori-Adjei, D; Mikus, G; Eichelbaum, M
      Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population

      PHARMACOGENETICS
    64. Chida, M; Yokoi, T; Kosaka, Y; Chiba, K; Nakamura, H; Ishizaki, T; Yokota, J; Kinoshita, M; Sato, K; Inaba, M; Aoki, Y; Gonzalez, FJ; Kamataki, T
      Genetic polymorphism of CYP2D6 in the Japanese population

      PHARMACOGENETICS
    65. Lessard, E; Yessine, MA; Hamelin, BA; O'Hara, G; LeBlanc, J; Turgeon, J
      Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans

      PHARMACOGENETICS
    66. Rostami-Hodjegan, A; Kroemer, HK; Tucker, GT
      In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity

      PHARMACOGENETICS
    67. Chida, M; Yokoi, T; Nemoto, N; Inaba, M; Kinoshita, M; Kamataki, T
      A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype

      PHARMACOGENETICS
    68. Jorge, LF; Eichelbaum, M; Griese, EU; Inaba, T; Arias, TD
      Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations

      PHARMACOGENETICS
    69. Arvidsson, PI; Hilmersson, G; Davidsson, O
      Rational design of chiral lithium amides for asymmetric alkylation reactions - NMR spectroscopic studies of mixed lithium amide/alkyllithium complexes

      CHEMISTRY-A EUROPEAN JOURNAL
    70. Norsikian, S; Marek, I; Klein, S; Poisson, JF; Normant, JF
      Enantioselective carbometalation of cinnamyl derivatives: New access to chiral disubstituted cyclopropanes - Configurational stability of benzylic organozinc halides

      CHEMISTRY-A EUROPEAN JOURNAL
    71. van Bebber, J; Ahrens, H; Frohlich, R; Hoppe, D
      Efficient desymmetrization of meso-cis-1,2-cyclohexanedimethanol with differentiation between diastereotopic and enantiotopic C-H bonds by (-)-sparteine-mediated deprotonation

      CHEMISTRY-A EUROPEAN JOURNAL
    72. Wurthwein, EU; Behrens, K; Hoppe, D
      Enantioselective deprotonation of alkyl carbamates by means of (R,R)-1,2-Bis(N,N-dimethylamino)cyclohexane/sec-butyllithium - Theory and experiment

      CHEMISTRY-A EUROPEAN JOURNAL
    73. Heinl, T; Retzow, S; Hoppe, D; Fraenkel, G; Chow, A
      Experimental and theoretical investigations of lithio-indenyl carbamate/(-)-sparteine and (-)-alpha-isosparteine complexes

      CHEMISTRY-A EUROPEAN JOURNAL
    74. Barberis, C; Voyer, N
      Synthesis of both enantiomers of phenylglycine using (-)-sparteine

      SYNLETT
    75. Borowiak, T; Dutkiewicz, G; Wysocka, W; Kolanos, R
      Thioanalogs of sparteine lactams [6]. Part II. (+)-2-thionosparteinium perchlorate

      ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES
    76. Cohen, LG; Biederman, J; Wilens, TE; Spencer, TJ; Mick, E; Faraone, SV; Prince, J; Flood, JG
      Desipramine clearance in children and adolescents: Absence of effect of development and gender

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    77. Yu, B; Ruckenstein, E
      Controlled radical polymerization catalyzed by copper(I)-sparteine complexes

      JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
    78. Druid, H; Holmgren, P; Carlsson, B; Ahlner, J
      Cytochrome P450 2D6 (CYP2D6) genotyping on postmortem blood as a supplementary tool for interpretation of forensic toxicological results

      FORENSIC SCIENCE INTERNATIONAL
    79. Lundqvist, E; Johansson, I; Ingelman-Sundberg, M
      Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes

      GENE
    80. Ammon, S; Hofmann, U; Griese, EU; Gugeler, N; Mikus, G
      Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosing

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    81. Manap, RA; Wright, CE; Gregory, A; Rostami-Hodjegan, A; Meller, ST; Kelm, GR; Lennard, MS; Tucker, GT; Morice, AH
      The antitussive effect of dextromethorphan in relation to CYP2D6 activity

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    82. Bathum, L; Skjelbo, E; Mutabingwa, TK; Madsen, H; Horder, M; Brosen, K
      Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    83. Hamelin, BA; Dorson, PG; Pabis, D; Still, D; Bouchard, RH; Pourcher, E; Rail, J; Turgeon, J; Crismon, ML
      CYP2D6 mutations and therapeutic outcome in schizophrenic patients

      PHARMACOTHERAPY
    84. DeVane, CL
      Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors

      CELLULAR AND MOLECULAR NEUROBIOLOGY
    85. Greenblatt, DJ; Von Moltke, LL; Harmatz, JS; Shader, RI
      Human cytochromes and some newer antidepressants: Kinetics, metabolism, and drug interactions

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    86. Tanaka, E
      Gender-related differences in pharmacokinetics and their clinical significance

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    87. Tanaka, E
      Clinically significant pharmacokinetic drug interactions between antiepileptic drugs

      JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
    88. Chen, SQ; Wedlund, PJ
      Correlation between cytochrome P-450CYP2D6 CYP2D6) genotype and phenotype

      ACTA PHARMACOLOGICA SINICA
    89. Haffen, E; Vandel, P; Broly, F; Vandel, S; Sechter, D; Bizouard, P; Bechtel, PR
      Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype

      PHARMACOPSYCHIATRY
    90. Avenoso, A; Facciola, G; Scordo, MG; Spina, E
      No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers

      THERAPEUTIC DRUG MONITORING
    91. Ohman, R; Hagg, S; Carleborg, L; Spigset, O
      Excretion of paroxetine into breast milk

      JOURNAL OF CLINICAL PSYCHIATRY
    92. Haffen, E; Vandel, P; Bonin, B; Vandel, S
      Citalopram pharmacokinetic interaction with clomipramine. UDP-glucuronosyltransferase inhibition? A case report

      THERAPIE
    93. Gawley, RE
      A proposal for (slight) modification of the Hughes-Ingold mechanistic descriptors for substitution reactions

      TETRAHEDRON LETTERS
    94. Bremand, N; Marek, I; Normant, JF
      Regioselective addition of nbutyllithium on secondary cinnamyl amides: "Michael" versus "contra-Michael" process

      TETRAHEDRON LETTERS
    95. Bremand, N; Marek, I; Normant, JF
      Diastereoselective "contra-Michael" addition of (-)-sparteine/organolithium complexes to secondary chiral cinnamyl amides

      TETRAHEDRON LETTERS
    96. Oestreich, M; Hoppe, D
      (-)-sparteine-mediated stereoselective intramolecular conjugate addition reactions of dienes and enynes

      TETRAHEDRON LETTERS
    97. Schwerdtfeger, J; Kolczewski, S; Weber, B; Frohlich, R; Hoppe, D
      Stereoselective deprotonation of chiral and achiral 2-aminoalkyl carbamates: Synthesis of optically active beta-amino alcohols via 1-oxy-substituted alkyllithium intermediates

      SYNTHESIS-STUTTGART
    98. Weber, B; Schwerdtfeger, J; Frohlich, R; Gohrt, A; Hoppe, D
      Diastereoselective lithiation and substitution of (S)-N-benzylprolinol andrac-N-benzylpiperidine-2-methanol via the carbamate esters: Kinetic resolution by means of (-)-sparteine-mediated deprotonation

      SYNTHESIS-STUTTGART
    99. Kortunay, S; Bozkurt, A; Bathum, L; Basci, NE; Calguneri, M; Brosen, K; Kayaalp, SO
      CYP2D6 polymorphism in systemic lupus erythematosus patients

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    100. Curtis, MD; Beak, P
      Asymmetric carbon-carbon bond formation in Michael reactions: Conjugate addition reactions of configurationally stable benzylic and allylic organolithium species

      JOURNAL OF ORGANIC CHEMISTRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 14:35:22